2016
DOI: 10.1126/scitranslmed.aaf2140
|View full text |Cite
|
Sign up to set email alerts
|

First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases

Abstract: A novel inhibitor of interactions between signaling proteins in T cells demonstrates promising preventive and therapeutic effects in several models of autoimmune disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
56
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(62 citation statements)
references
References 51 publications
5
56
0
1
Order By: Relevance
“…Interestingly, the T‐cell response to a mouse pathogen acting as a strong high‐affinity peptide was normal after treatment with this inhibitor. Altogether, these results indicate that this synthetic inhibitor could be a candidate to be evaluated in clinical trials to treat various T‐cell‐mediated autoimmune diseases …”
Section: Nckmentioning
confidence: 86%
See 2 more Smart Citations
“…Interestingly, the T‐cell response to a mouse pathogen acting as a strong high‐affinity peptide was normal after treatment with this inhibitor. Altogether, these results indicate that this synthetic inhibitor could be a candidate to be evaluated in clinical trials to treat various T‐cell‐mediated autoimmune diseases …”
Section: Nckmentioning
confidence: 86%
“…72 Hence, the requirement of Nck recruitment for T-cell activation only by low (and not by high) affinity antigens has raised the possibility for inhibition of the Nck-CD3 interaction as a target for treatment of autoimmune diseases caused by self-reactive T cells. Borroto et al 73 have chemically generated a lowmolecular-weight inhibitor targeting a non-canonical pocket within the Nck SH3.1 domain. As expected, this inhibitor prevented the binding of Nck to the TCR-CD3 complex.…”
Section: Nckmentioning
confidence: 99%
See 1 more Smart Citation
“…Таким образом, патологии в структуре этого ком-плекса могут привести к дисфункции Т-к леток и развитию аутоиммунных заболеваний, таких как аутоиммунный сахарный диабет, системная красная волчанка и системная склеродермия [46]. Поскольку большинство аутоиммунных заболеваний считают-ся специфичными к антигену, то патология в струк-туре Т-клеточного рецептора, или нарушение его функциональной активности играют решающую роль в патогенезе заболеваний [13,89]. Каждый рецепторный комплекс имеет связи с вну-триклеточной системой ферментов, наиболее важ-ной являются тирозинкиназы, фосфотазы.…”
Section: роль рецепторов и ферментов в патогенезе миастении грависunclassified
“…15,16 Both isoforms consist of three SH3 domains (SH3Á1, SH3Á2 and SH3Á3) and one SH2 domain, and so potentially interact with proline-rich sequence (PRS)-bearing proteins and tyrosine phosphorylated proteins, respectively. Indeed, inhibiting the Nck-TCR interaction reduced actin polymerization, 24 showing that the Nck pool at the TCR significantly contributes to actin rearrangements. 20 Nck also functions as a linker for the recruitment and activation of other proteins in multiple intracellular signaling pathways.…”
Section: Introductionmentioning
confidence: 97%